{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T14:41:22Z","timestamp":1789224082328,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T00:00:00Z","timestamp":1616371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T00:00:00Z","timestamp":1616371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U01AG029824"],"award-info":[{"award-number":["U01AG029824"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s11606-020-06550-2","type":"journal-article","created":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T22:02:21Z","timestamp":1616450541000},"page":"1629-1637","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["A Cohort Study of Anticholinergic Medication Burden and Incident Dementia and Stroke in Older Adults"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6664-1239","authenticated-orcid":false,"given":"Jessica E.","family":"Lockery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C.","family":"Broder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley C.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn L.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor T.-J.","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey C.","family":"Cloud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Rigby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsdon","family":"Storey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory","family":"Wolfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taya A.","family":"Collyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the ASPREE Investigator Group, ASPREE Investigator Group listed on www.aspree.org","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,22]]},"reference":[{"issue":"5","key":"6550_CR1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S1474-4422(19)30034-1","volume":"18","author":"CO Johnson","year":"2019","unstructured":"Johnson CO, Nguyen M, Roth GA, Nichols E, Alam T, Abate D, et al. Global, regional, and national burden of stroke, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019 May 1;18(5):439\u201358.","journal-title":"Lancet Neurol."},{"issue":"1","key":"6550_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","volume":"18","author":"E Nichols","year":"2019","unstructured":"Nichols E, Szoeke CEI, Vollset SE, Abbasi N, Abd-Allah F, Abdela J, et al. Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019 Jan 1;18(1):88\u2013106.","journal-title":"Lancet Neurol."},{"issue":"2","key":"6550_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1365-2125.2004.02232.x","volume":"59","author":"N Lechevallier-Michel","year":"2005","unstructured":"Lechevallier-Michel N, Molimard M, Dartigues J-F, Fabrigoule C, Fourrier-R\u00e9glat A. Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study. Br J Clin Pharmacol. 2005 Feb;59(2):143\u201351.","journal-title":"Br J Clin Pharmacol."},{"issue":"14","key":"6550_CR4","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/archinternmed.2009.229","volume":"169","author":"I Carri\u00e8re","year":"2009","unstructured":"Carri\u00e8re I, Fourrier-Reglat A, Dartigues J-F, Rouaud O, Pasquier F, Ritchie K, et al. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch Intern Med. 2009 Jul;169(14):1317\u201324.","journal-title":"Arch Intern Med."},{"issue":"2","key":"6550_CR5","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/ije\/dyx265","volume":"47","author":"DT Gamble","year":"2018","unstructured":"Gamble DT, Clark AB, Luben RN, Wareham NJ, Khaw K-T, Myint PK. Baseline anticholinergic burden from medications predicts incident fatal and non-fatal stroke in the EPIC-Norfolk general population. Int J Epidemiol. 2018 Apr 1;47(2):625\u201333.","journal-title":"Int J Epidemiol."},{"issue":"2","key":"6550_CR6","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3233\/JAD-180353","volume":"65","author":"ECK Tan","year":"2018","unstructured":"Tan ECK, Eriksdotter M, Garcia-Ptacek S, Fastbom J, Johnell K. Anticholinergic burden and risk of stroke and death in people with different types of dementia. J Alzheimers Dis JAD. 2018;65(2):589\u201396.","journal-title":"J Alzheimers Dis JAD."},{"key":"6550_CR7","doi-asserted-by":"crossref","unstructured":"Richardson K, Fox C, Maidment I, Steel N, Loke YK, Arthur A, et al. Anticholinergic drugs and risk of dementia: case-control study. BMJ [Internet]. 2018 Apr 25 [cited 2019 Dec 1];361. Available from: https:\/\/www.bmj.com\/content\/361\/bmj.k1315","DOI":"10.1136\/bmj.k1315"},{"issue":"8","key":"6550_CR8","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1001\/jamainternmed.2019.0677","volume":"179","author":"CAC Coupland","year":"2019","unstructured":"Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic drug exposure and the risk of dementia: a nested case-control study. JAMA Intern Med. 2019 Aug 1;179(8):1084\u201393.","journal-title":"JAMA Intern Med."},{"issue":"3","key":"6550_CR9","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","volume":"175","author":"SL Gray","year":"2015","unstructured":"Gray SL, Anderson ML, Dublin S, Hanlon JT, Hubbard R, Walker R, et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med. 2015 Mar 1;175(3):401\u20137.","journal-title":"JAMA Intern Med."},{"key":"6550_CR10","first-page":"135","volume":"5","author":"BN Justin","year":"2013","unstructured":"Justin BN, Turek M, Hakim AM. Heart disease as a risk factor for dementia. Clin Epidemiol. 2013 Apr 26;5:135\u201345.","journal-title":"Clin Epidemiol."},{"issue":"6","key":"6550_CR11","doi-asserted-by":"publisher","first-page":"e000369","DOI":"10.1161\/JAHA.113.000369","volume":"2","author":"B Haring","year":"2013","unstructured":"Haring B, Leng X, Robinson J, Johnson KC, Jackson RD, Beyth R, et al. Cardiovascular disease and cognitive decline in postmenopausal women: results from the Women\u2019s Health Initiative Memory Study. J Am Heart Assoc. 2013 Dec 18;2(6):e000369.","journal-title":"J Am Heart Assoc."},{"key":"6550_CR12","doi-asserted-by":"crossref","unstructured":"Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial. Contemp Clin Trials. 2013 Nov 1;36(2):555\u201364.","DOI":"10.1016\/j.cct.2013.09.014"},{"issue":"8","key":"6550_CR13","first-page":"314","volume":"48","author":"EL Teng","year":"1987","unstructured":"Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry. 1987 Aug;48(8):314\u20138.","journal-title":"J Clin Psychiatry."},{"issue":"6","key":"6550_CR14","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1177\/070674370104600604","volume":"46","author":"RC Bland","year":"2001","unstructured":"Bland RC, Newman SC. Mild dementia or cognitive impairment: the Modified Mini-Mental State examination (3MS) as a screen for dementia. Can J Psychiatry Rev Can Psychiatr. 2001 Aug;46(6):506\u201310.","journal-title":"Can J Psychiatry Rev Can Psychiatr."},{"issue":"11","key":"6550_CR15","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1093\/gerona\/glw342","volume":"72","author":"JJ McNeil","year":"2017","unstructured":"McNeil JJ, Woods RL, Nelson MR, Murray AM, Reid CM, Kirpach B, et al. Baseline characteristics of participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study. J Gerontol A Biol Sci Med Sci. 2017 Oct;72(11):1586\u201393.","journal-title":"J Gerontol A Biol Sci Med Sci."},{"key":"6550_CR16","doi-asserted-by":"crossref","unstructured":"McNeil JJ, Woods RL, Nelson MR, Reid CM, Kirpach B, Wolfe R, et al. Effect of aspirin on disability-free survival in the healthy elderly. N Engl J Med. 2018 Sep 16;0(0):null.","DOI":"10.1056\/NEJMoa1800722"},{"issue":"16","key":"6550_CR17","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1056\/NEJMoa1803955","volume":"379","author":"JJ McNeil","year":"2018","unstructured":"McNeil JJ, Nelson MR, Woods RL, Lockery JE, Wolfe R, Reid CM, et al. Effect of aspirin on all-cause mortality in the healthy elderly. N Engl J Med. 2018 Oct 18;379(16):1519\u201328.","journal-title":"N Engl J Med."},{"issue":"16","key":"6550_CR18","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa1805819","volume":"379","author":"JJ McNeil","year":"2018","unstructured":"McNeil JJ, Wolfe R, Woods RL, Tonkin AM, Donnan GA, Nelson MR, et al. Effect of aspirin on cardiovascular events and bleeding in the healthy elderly. N Engl J Med. 2018 Oct 18;379(16):1509\u201318.","journal-title":"N Engl J Med."},{"issue":"4","key":"6550_CR19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.5694\/mja2.12060","volume":"210","author":"JE Lockery","year":"2019","unstructured":"Lockery JE, Collyer TA, Abhayaratna WP, Fitzgerald SM, McNeil JJ, Nelson MR, et al. Recruiting general practice patients for large clinical trials: lessons from the Aspirin in Reducing Events in the Elderly (ASPREE) study. Med J Aust. 2019 Jan 28;210(4):168\u201373.","journal-title":"Med J Aust."},{"issue":"1","key":"6550_CR20","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1186\/s13063-019-3789-2","volume":"20","author":"JE Lockery","year":"2019","unstructured":"Lockery JE, Collyer TA, Reid CM, Ernst ME, Gilbertson D, Hay N, et al. Overcoming challenges to data quality in the ASPREE clinical trial. Trials. 2019 Dec 9;20(1):686.","journal-title":"Trials."},{"key":"6550_CR21","unstructured":"WHOCC - ATC\/DDD Index [Internet]. [cited 2019 Oct 3]. Available from: https:\/\/www.whocc.no\/atc_ddd_index\/"},{"issue":"12","key":"6550_CR22","doi-asserted-by":"publisher","first-page":"e0226868","DOI":"10.1371\/journal.pone.0226868","volume":"14","author":"JE Lockery","year":"2019","unstructured":"Lockery JE, Rigby J, Collyer TA, Stewart AC, Woods RL, McNeil JJ, et al. Optimising medication data collection in a large-scale clinical trial. PLOS ONE. 2019 Dec 27;14(12):e0226868.","journal-title":"PLOS ONE."},{"issue":"3","key":"6550_CR23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2217\/1745509X.4.3.311","volume":"4","author":"M Boustani","year":"2008","unstructured":"Boustani M, Campbell N, Munger S, Maidment I, Fox C. Impact of anticholinergics on the aging brain: a review and practical application. Aging Health. 2008 Jun 1;4(3):311\u201320.","journal-title":"Aging Health."},{"key":"6550_CR24","first-page":"225","volume":"4","author":"N Campbell","year":"2009","unstructured":"Campbell N, Boustani M, Limbil T, Ott C, Fox C, Maidment I, et al. The cognitive impact of anticholinergics: a clinical review. Clin Interv Aging. 2009;4:225\u201333.","journal-title":"Clin Interv Aging."},{"issue":"8","key":"6550_CR25","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1111\/j.1532-5415.2011.03491.x","volume":"59","author":"C Fox","year":"2011","unstructured":"Fox C, Richardson K, Maidment ID, Savva GM, Matthews FE, Smithard D, et al. Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. J Am Geriatr Soc. 2011 Aug;59(8):1477\u201383.","journal-title":"J Am Geriatr Soc."},{"issue":"5","key":"6550_CR26","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1001\/archinternmed.2007.106","volume":"168","author":"JL Rudolph","year":"2008","unstructured":"Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med. 2008 Mar 10;168(5):508\u201313.","journal-title":"Arch Intern Med."},{"issue":"12","key":"6550_CR27","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1177\/0091270006292126","volume":"46","author":"RM Carnahan","year":"2006","unstructured":"Carnahan RM, Lund BC, Perry PJ, Pollock BG, Culp KR. The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol. 2006 Dec;46(12):1481\u20136.","journal-title":"J Clin Pharmacol."},{"key":"6550_CR28","doi-asserted-by":"crossref","unstructured":"Ryan J, Woods RL, Britt C, Murray AM, Shah RC, Reid CM, et al. Normative performance of healthy older individuals on the Modified Mini-Mental State (3MS) examination according to ethno-racial group, gender, age, and education level. Clin Neuropsychol [Internet]. 2019 May 19 [cited 2019 Dec 23];33(4). Available from: https:\/\/research.monash.edu\/en\/publications\/normative-performance-of-healthy-older-individuals-on-the-modifie","DOI":"10.1080\/13854046.2018.1488996"},{"key":"6550_CR29","unstructured":"Ryan J, Storey E, Murray A, Woods RL, Wolfe R, Reid CM, et al. Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline."},{"issue":"4","key":"6550_CR30","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.acn.2004.11.004","volume":"20","author":"TN Tombaugh","year":"2005","unstructured":"Tombaugh TN. Test-retest reliable coefficients and 5-year change scores for the MMSE and 3MS. Arch Clin Neuropsychol Off J Natl Acad Neuropsychol. 2005 Jun;20(4):485\u2013503.","journal-title":"Arch Clin Neuropsychol Off J Natl Acad Neuropsychol."},{"key":"6550_CR31","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Washington, DC: American Psychiatric Association; 1994."},{"issue":"3","key":"6550_CR32","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement J Alzheimers Assoc. 2011 May;7(3):263\u20139.","journal-title":"Alzheimers Dement J Alzheimers Assoc."},{"key":"6550_CR33","doi-asserted-by":"crossref","unstructured":"Stroke--1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders. Stroke. 1989 Oct;20(10):1407\u201331.","DOI":"10.1161\/01.STR.20.10.1407"},{"issue":"3","key":"6550_CR34","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1177\/1747493017741383","volume":"13","author":"R Wolfe","year":"2018","unstructured":"Wolfe R, Murray AM, Woods RL, Kirpach B, Gilbertson D, Shah RC, et al. The ASPirin in Reducing Events in the Elderly trial: statistical analysis plan. Int J Stroke Off J Int Stroke Soc. 2018 Apr;13(3):335\u20138.","journal-title":"Int J Stroke Off J Int Stroke Soc."},{"issue":"4","key":"6550_CR35","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.2307\/2532457","volume":"46","author":"R Brant","year":"1990","unstructured":"Brant R. Assessing proportionality in the proportional odds model for ordinal logistic regression. Biometrics. 1990 Dec;46(4):1171\u20138.","journal-title":"Biometrics."},{"issue":"3","key":"6550_CR36","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/014662167700100306","volume":"1","author":"LS Radloff","year":"1977","unstructured":"Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977 Jun 1;1(3):385\u2013401.","journal-title":"Appl Psychol Meas."},{"issue":"12","key":"6550_CR37","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/pds.4902","volume":"28","author":"K Joung","year":"2019","unstructured":"Joung K, Shin J-Y, Cho S. Features of anticholinergic prescriptions and predictors of high use in the elderly: population-based study. Pharmacoepidemiol Drug Saf. 2019 Dec 1;28(12):1591\u2013600.","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"8","key":"6550_CR38","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1111\/ggi.13330","volume":"18","author":"D Sevilla-S\u00e1nchez","year":"2018","unstructured":"Sevilla-S\u00e1nchez D, Molist-Brunet N, Gonz\u00e1lez-Bueno J, Sol\u00e0-Bonada N, Espaulella-Panicot J, Codina-Jan\u00e9 C. Prevalence, risk factors and adverse outcomes of anticholinergic burden in patients with advanced chronic conditions at hospital admission. Geriatr Gerontol Int. 2018 Aug;18(8):1159\u201365.","journal-title":"Geriatr Gerontol Int."},{"issue":"4","key":"6550_CR39","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jamda.2008.11.005","volume":"10","author":"A Kolanowski","year":"2009","unstructured":"Kolanowski A, Fick DM, Campbell J, Litaker M, Boustani M. A Preliminary study of anticholinergic burden and relationship to a quality of life indicator, engagement in activities, in nursing home residents with dementia. J Am Med Dir Assoc. 2009 May 1;10(4):252\u20137.","journal-title":"J Am Med Dir Assoc."},{"issue":"11","key":"6550_CR40","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jamda.2014.08.002","volume":"15","author":"F Landi","year":"2014","unstructured":"Landi F, Dell\u2019Aquila G, Collamati A, Martone AM, Zuliani G, Gasperini B, et al. Anticholinergic drug use and negative outcomes among the frail elderly population living in a nursing home. J Am Med Dir Assoc. 2014 Nov 1;15(11):825\u20139.","journal-title":"J Am Med Dir Assoc."},{"issue":"12","key":"6550_CR41","doi-asserted-by":"publisher","first-page":"987","DOI":"10.2165\/11584430-000000000-00000","volume":"27","author":"S Chatterjee","year":"2010","unstructured":"Chatterjee S, Mehta S, Sherer JT, Aparasu RR. Prevalence and predictors of anticholinergic medication use in elderly nursing home residents with dementia. Drugs Aging. 2010 Dec 1;27(12):987\u201397.","journal-title":"Drugs Aging."},{"issue":"5","key":"6550_CR42","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/ana.21509","volume":"64","author":"H Amieva","year":"2008","unstructured":"Amieva H, Le Goff M, Millet X, Orgogozo JM, P\u00e9r\u00e8s K, Barberger-Gateau P, et al. Prodromal Alzheimer\u2019s disease: successive emergence of the clinical symptoms. Ann Neurol. 2008 Nov;64(5):492\u20138.","journal-title":"Ann Neurol."},{"key":"6550_CR43","doi-asserted-by":"crossref","unstructured":"Singh-Manoux A, Dugravot A, Fournier A, Abell J, Ebmeier K, Kivim\u00e4ki M, et al. Trajectories of depressive symptoms before diagnosis of dementia: a 28-year follow-up study. JAMA Psychiatry. 2017 01;74(7):712\u20138.","DOI":"10.1001\/jamapsychiatry.2017.0660"},{"key":"6550_CR44","doi-asserted-by":"crossref","unstructured":"Lang L, Clifford A, Wei L, Zhang D, Leung D, Augustine G, et al. Prevalence and determinants of undetected dementia in the community: a systematic literature review and a meta-analysis. BMJ Open [Internet]. 2017 Feb 3 [cited 2019 Dec 1];7(2). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5293981\/","DOI":"10.1136\/bmjopen-2016-011146"},{"key":"6550_CR45","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/j.1749-6632.2000.tb06388.x","volume":"903","author":"AE Roher","year":"2000","unstructured":"Roher AE, Kuo YM, Potter PE, Emmerling MR, Durham RA, Walker DG, et al. Cortical cholinergic denervation elicits vascular A beta deposition. Ann N Y Acad Sci. 2000 Apr;903:366\u201373.","journal-title":"Ann N Y Acad Sci."},{"issue":"1","key":"6550_CR46","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1213\/00000539-199701000-00027","volume":"84","author":"JM van Vlymen","year":"1997","unstructured":"van Vlymen JM, Parlow JL. The effects of reversal of neuromuscular blockade on autonomic control in the perioperative period. Anesth Analg. 1997 Jan;84(1):148\u201354.","journal-title":"Anesth Analg."},{"issue":"4","key":"6550_CR47","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1378\/chest.118.4.914","volume":"118","author":"J Mathew","year":"2000","unstructured":"Mathew J, Hunsberger S, Fleg J, Sherry FM, Williford W, Yusuf S. Incidence, predictive factors, and prognostic significance of supraventricular tachyarrhythmias in congestive heart failure. CHEST. 2000 Oct 1;118(4):914\u201322.","journal-title":"CHEST."},{"key":"6550_CR48","doi-asserted-by":"crossref","unstructured":"Hooft CS van der, Heeringa J, Herpen G van, Kors JA, Kingma JH, Stricker BHC. Drug-induced atrial fibrillation. J Am Coll Cardiol. 2004 Dec 7;44(11):2117\u201324.","DOI":"10.1016\/j.jacc.2004.08.053"},{"issue":"6","key":"6550_CR49","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1001\/jamaneurol.2016.0580","volume":"73","author":"SL Risacher","year":"2016","unstructured":"Risacher SL, McDonald BC, Tallman EF, West JD, Farlow MR, Unverzagt FW, et al. Association between anticholinergic medication use and cognition, brain metabolism, and brain atrophy in cognitively normal older adults. JAMA Neurol. 2016 Jun 1;73(6):721\u201332.","journal-title":"JAMA Neurol."},{"issue":"1","key":"6550_CR50","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1136\/thoraxjnl-2011-201275","volume":"68","author":"S Singh","year":"2013","unstructured":"Singh S, Loke YK, Enright P, Furberg CD. Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications. Thorax. 2013 Jan 1;68(1):114\u20136.","journal-title":"Thorax."},{"key":"6550_CR51","doi-asserted-by":"crossref","unstructured":"Yuan W, Nie S, Wang H, Xu Q, Jia N. Anticholinergics aggravate the imbalance of the autonomic nervous system in stable chronic obstructive pulmonary disease. BMC Pulm Med [Internet]. 2019 May 9 [cited 2019 Dec 1];19. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6506959\/","DOI":"10.1186\/s12890-019-0848-0"},{"issue":"1\u20132","key":"6550_CR52","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jneuroim.2007.11.019","volume":"194","author":"S Razani-Boroujerdi","year":"2008","unstructured":"Razani-Boroujerdi S, Behl M, Hahn FF, Pena-Philippides JC, Hutt J, Sopori ML. Role of muscarinic receptors in the regulation of immune and inflammatory responses. J Neuroimmunol. 2008 Feb;194(1\u20132):83\u20138.","journal-title":"J Neuroimmunol."},{"key":"6550_CR53","doi-asserted-by":"crossref","unstructured":"McGeer PL, Rogers J, McGeer EG. Inflammation, antiinflammatory agents, and Alzheimer\u2019s disease: the last 22 years. J Alzheimers Dis JAD. 2016 04;54(3):853\u20137.","DOI":"10.3233\/JAD-160488"},{"issue":"5","key":"6550_CR54","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s40520-016-0637-z","volume":"29","author":"F Guerriero","year":"2017","unstructured":"Guerriero F, Sgarlata C, Francis M, Maurizi N, Faragli A, Perna S, et al. Neuroinflammation, immune system and Alzheimer disease: searching for the missing link. Aging Clin Exp Res. 2017 Oct;29(5):821\u201331.","journal-title":"Aging Clin Exp Res."},{"key":"6550_CR55","unstructured":"Smith A, Services (Firm) WP. Symbol digit modalities test : manual [Internet]. Los Angeles, Calif. : Western Psychological Corporation; 2002 [cited 2018 Nov 1]. Available from: https:\/\/trove.nla.gov.au\/version\/42656069"},{"issue":"2","key":"6550_CR56","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/arclin\/18.2.153","volume":"18","author":"TP Ross","year":"2003","unstructured":"Ross TP. The reliability of cluster and switch scores for the Controlled Oral Word Association Test. Arch Clin Neuropsychol Off J Natl Acad Neuropsychol. 2003 Mar;18(2):153\u201364.","journal-title":"Arch Clin Neuropsychol Off J Natl Acad Neuropsychol."},{"issue":"1","key":"6550_CR57","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1076\/clin.12.1.43.1726","volume":"12","author":"RHB Benedict","year":"1998","unstructured":"Benedict RHB, Schretlen D, Groninger L, Brandt J. Hopkins Verbal Learning Test \u2013 revised: normative data and analysis of inter-form and test-retest reliability. Clin Neuropsychol. 1998 Feb 1;12(1):43\u201355.","journal-title":"Clin Neuropsychol."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-020-06550-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-020-06550-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-020-06550-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T06:42:24Z","timestamp":1675060944000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-020-06550-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,22]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["6550"],"URL":"https:\/\/doi.org\/10.1007\/s11606-020-06550-2","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,22]]},"assertion":[{"value":"3 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they do not have a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Ethics approval was obtained for all study sites. In the USA, ethics approval was granted by the relevant Institutional Review Board at study sites. In Australia, primary ethics approval was granted by Monash University Human Research Ethics Committee [CF07\/3730 - 2006\/745MC]. All participants provided informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approvals"}},{"value":"The datasets used and\/or analyzed for this publication are available via the ASPREE Principal Investigators. Requests for data access can be directed to aspree.ams@monash.edu","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}